Advertisement

20th International AIDS Conference (AIDS 2014)

News

Higher ART Coverage Is Associated With Lower HIV Infection Rates in a Multi-Country Analysis

August 1, 2014

If all low- and middle-income countries had achieved the same level of antiretroviral treatment (ART) coverage as Botswana in 2012, 65% of new HIV infections and 70% of HIV-related deaths could have been prevented -- according to an analysis presented at AIDS 2014.1

A multi-country survey by Andrew Hill and colleagues from the University of Liverpool, St Stephens Centre, London, Imperial College, London and World Health Organisation -- presented as a late breaker poster -- looked at the relationship between the percentage of HIV positive people on ART to HIV incidence and related deaths. The analysis also compared ART coverage rates between low-, middle- and high-income countries.

The researchers used 2012 UNAIDS country-level estimates for 51 low- and middle-income countries: 36 from African and 15 non-African with at least 50,000 people with HIV. Data from published references were used for the seven high-income countries but these were not used in the calculations of the associations between coverage and incidence. Weighted least squares and linear regression models were used in the investigations.

Advertisement
The mean percentage of ART coverage across the low- and middle-income countries was 30% with a wide variation ranging from 0.6% in Madagascar to 62% in Botswana. The mean percentage of new HIV infections was 6.1% and this ranged from 2% in Thailand to 12.5% in Indonesia.

The researchers found a highly significant association between greater ART coverage and both lower percentage incidence and HIV-related deaths (p<0.00001 for both associations). Each 10% increase in ART coverage was associated with a 1.15% reduction in new infections and a 1.13% reduction in HIV-related deaths.

Further analyses suggested that the same level of coverage as Botswana (62%) across all low- and middle-income countries could have prevented 1,243,647 of the 1,901,800 (65%) new HIV infections in 2012. In the same period, under the same conditions, 998,732 out of 1,427,200 (70%) deaths from HIV could have been prevented.

The 51 countries in the analysis plus seven high income ones were ranked according to percentage of HIV positive people receiving ART. Levels of coverage across high-income countries also varied considerably from 67% in the UK to 33% in the US. The US ranked 30th out of 58 countries -- between Burandi and Uganda.

The researchers wrote: "The results provide a compelling argument for continuing to improve antiretroviral treatment coverage worldwide."


Comment

Andrew Hill also presented these data in a workshop on trial design for low-income countries.2 He noted that in the UK the breakpoint in the cascade was between the estimated number of HIV positive people and diagnosis/link to care, respectively 98,400 and 77,610 (79%).

Dr. Hill remarked that there are many other differences between countries, which might explain these associations. For example countries with better treatment coverage might also have better HIV prevention programmes.

He also pointed out variability around the association -- some countries have high rates of new infections, despite high ART coverage, such as Uganda, or low infection rates despite lower ART coverage, as in Niger.

The analysis is being repeated using the new 2013 UNAIDS database, for validation. The researchers will look in detail at the methods used by UNAIDS to estimate their rates of new HIV infections and deaths, and refine their methods.


References

  1. Hill A et al. Higher antiretroviral treatment coverage is associated with lower adult HIV infection rates: analysis of 51 low and middle-income countries. 20th International AIDS Conference. Melbourne. 20-25 July 2014. Late breaker poster abstract LBPE29.
  2. Hill A. Is higher antiretroviral treatment coverage associated with lower HIV infection rates? 20th International AIDS Conference. Melbourne. 20-25 July, 2014. Workshop presentation TUWS1103.

Links to other websites are current at date of posting but not maintained.




This article was provided by HIV i-Base. It is a part of the publication HIV Treatment Bulletin. Visit HIV i-Base's website to find out more about their activities, publications and services.
 


No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.